ST
CTSO icon

Smithfield Trust’s Cytosorbents Corp CTSO Stock Holding History

Smithfield Trust’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,200
Closed -$20K – 1077
2022
Q1 		$20K Hold
6,200
– – ﹤0.01% 698
2021
Q4 		$26K Hold
6,200
– – ﹤0.01% 663
2021
Q3 		$50K Hold
6,200
– – ﹤0.01% 563
2021
Q2 		$47K Buy
+6,200
New +$52.2K ﹤0.01% 561

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Smithfield Trust's CTSO Position: Q2 2022 in Review

Smithfield Trust sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 6,200 shares — an estimated $20K sold.

Smithfield Trust first reported a position in CTSO in Q2 2021 and held it in 4 quarters. The position peaked at $50K in Q3 2021. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

  • Smithfield Trust reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
  • Smithfield Trust sold 6,200 Cytosorbents Corp shares in Q2 2022, an estimated $20K.
  • Smithfield Trust first reported a position in Cytosorbents Corp in Q2 2021 and held it in 4 quarters.
  • Smithfield Trust's Cytosorbents Corp position peaked at $50K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Smithfield Trust's 13F filing for Q2 2022, filed 11 Aug 2022.